Method of obtaining personal medication for treatment of diabetes, personal preparation obtained by said method, method of treating diabetes by said preparation

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the pharmaceutical industry, namely to a personal preparation from earthworms for treatment of diabetes. The method of obtaining the personal preparation from earthworms for treatment of diabetes includes placement of sexually mature earthworms in a medium, consisting of organics, which additionally contains a solution of a patient's urine, after that, the sexually mature earthworms are removed and for 3 months each 7-10 days fresh organic food is added to the remaining mass, after that, the sexually mature earthworms are separated, placed in a reservoir and sprayed with an alcohol solution, mixed, poured with the alcohol solution and placed into dark place under the specified temperature, with the solution being mixed daily, with further separation of the extract from the sediment. The personal preparation for treatment of diabetes.

EFFECT: application of the described above preparation increases efficiency of diabetes treatment.

3 cl, 3 dwg, 1 ex

 

The group of inventions relates to medicine and can be used in the pharmaceutical industry and in medical practice for treating diabetes.

Closest to the proposed method of obtaining personal treatment for diabetes is a method for the preparation of earthworms in the diet which was used containing food organics (see patent RU No. 2359685, publ. 27.06 2009).

The downside of it is the inability to obtain effective drug for the treatment of diseases of a particular person with its characteristics of the organism.

The technical objective of the proposed method is obtaining the personal drug for diabetes specific person, taking into account the peculiarities of his body, the simplification of the way, reducing the cost.

For this purpose, we propose a method of obtaining personal drug of earthworms in the diet which was used in the feed containing organic matter, which consists in the fact that the first Mature earthworms 20-30 days is placed in a medium consisting of organic matter, which additionally contains 5÷10% solution of urine of a sick person in the following ratio, wt.%:

Organics70÷85%
The solution urine rest

rate of not less than one kilogram of feed 30-40 g of worms, then adult worms were removed and within 3 months every 7-10 days to the remaining mass add fresh organic feed of the same composition, while maintaining the previous value of the mass of a new generation of worms and add the feed, after which adult worms are separated, placed in a container and sprayed with alcohol 60÷70% solution at the rate of 3-5 ml per 100 g of worms, mix thoroughly until the worms are no longer showing signs of life and then pour 60-70% alcohol solution based 150-160 ml per 100 g of worms and placed in a dark place for at least 10 days at a temperature of 17-24 degrees, and the solution is daily subjected to stirring, and then the extract is separated from the precipitate.

A distinctive feature of the proposed method against known is that Mature earthworms 20-30 days is placed in a medium consisting of organic matter, which additionally contains 5÷10% solution of urine of a sick person in the following ratio, wt.%:

Organics70÷85%
The solution urinerest

rate of not less than one kilogram of feed 30-40 g of worms, then the age-sex is elih individuals remove worms and within 3 months every 7-10 days to the remaining mass add fresh organic feed of the same composition, keeping the previous ratio of the mass of a new generation of worms and add the feed, after which adult worms are separated, placed in a container and sprayed with alcohol 60÷70% solution at the rate of 3-5 ml per 100 g of worms, mix thoroughly until the worms are no longer showing signs of life and then pour 60-70% alcohol solution based 150-160 ml per 100 g of worms and put in a dark place for at least 10 days at a temperature of 17-24 degrees, and the solution is daily subjected to stirring, and then the extract is separated from the precipitate.

Closest to the proposed method of treatment of diabetes personal preparation is a method of drug treatment (see patent RU No. 2359685, publ. 27.06 2009).

The disadvantage is low efficiency.

The technical objective of the proposed method is to increase the effectiveness of treatment, empowerment of the drug.

For this purpose, we propose a method of treating diabetes personal preparation obtained by the method according to claim 1, which consists in the fact that the impact on the patient's body lead by personal application of the drug on the projection area of the patient body on the body side of the abdomen and back are located most closely to the patients internal organs and the projection point responsible for immunity, and at first the drug is applied at t the value of 7-10 days daily in the amount of 0.5-1 ml of the lumbar spine and 0.5-1 ml per point responsible for immunity, then, every day for 1.5-2 ml corresponding projection point of diseased organs.

A distinctive feature of the proposed method against known is that the impact on the patient's body lead by personal application of the drug on the projection area of diseased organs on the body side of the abdomen and back, located closest to sick bodies and the projection point responsible for immunity, and at first the drug is applied within 7-10 days daily in the amount of 0.5-1 ml of the lumbar spine and 0.5-1 ml per point responsible for immunity, then, every day for 1.5-2 ml corresponding projection point of diseased organs.

The method of obtaining personal drug of earthworms in the diet which was used containing food organics is the following. First Mature earthworms 20-30 days is placed in a medium consisting of organic matter, which additionally contains 5÷10% solution of urine of a sick person in the following ratio, wt.%:

Organics70÷85%
The solution urinerest

rate of not less than one kilogram of feed 30-40 g of worms.

In the operation of organic manure of animals and (or) vegetable ingredients of agricultural crops and (or) waste grain and / or beer and / or alcohol and / or tin and / or wine and / or tea and / or oil industry. It uses organic material having a pH of 6.5÷7,5 held composting and fermentation. The humidity of the feed after application of urine should be 65-80%.

Indoors, where the feeding of the worms, the temperature of 18-24°C. Then, the adult worms were removed and within 3 months every 7-10 days to the remaining mass add fresh organic feed of the same composition, while maintaining the previous value of the mass of a new generation of worms and add the feed. After which adult worms are separated, placed in a container and sprayed with alcohol 60÷70% solution at the rate of 3-5 ml per 100 g of worms, mix thoroughly until the worms are no longer showing signs of life. In stressful conditions in the nervous system of the worm activates the neural networks that do not manifest themselves in normal conditions. These channels stimulates the production of a specific protein receptors increases the activity of the drug received.

(see http://www.sunhome.ru/journal/525687)

Next, the resulting mass is poured 60-70% alcohol solution based 150-160 ml per 100 g of worms and put in a dark place for at least 10 days at a temperature of 17-24 degrees, and the solution of egene is but is subjected to stirring. Next, the extract is separated from the precipitate.

Urine is a solution containing multiple components of metabolic products of organic substances which contain information about the illness of the person contributing this urine.

The basis of the method of preparation of this tool is the ability of the worm due to its powerful immune system to resist any viruses and germs and to adapt to almost any food, and thus to perceive (to neutralize, if it is dangerous for his life), to process all the information contained in this aft, to generate necessary for the correction of disease agents. Extragere worms, nutrition have used the urine of a sick person received medical personal tool.

Given that human urine contains information about the state of the human body, it is used as a means to obtain drugs can affect certain organs. The information transfer is carried out at the gene level, worms through their food, by making these information components (urine) in this feed.

Example: 100 grams of Mature worms is approximately 250 pieces was placed in a feed rate of not less than one kilogram of feed per 30 g of worms (10.4 kg). As feed was used organics containing 5% solution of urine pain the first man in the following ratio, wt.%:

Organics70%
The solution urinerest

As organics used last composting plant components of agricultural crops and animal manure (pH 6,8).

After application of urine humidity of the feed was 71%.

After 20 days received approximately 1750 young worms, while adult worms were removed and within 3 months every 7 days to the remaining mass was added fresh organic feed of the same composition, while maintaining the previous value of the mass of a new generation of worms and add the feed. After 3 months this part of the worms, which amounted to about 700 g grew to Mature age. These worms were separated from the remaining mass of hearts that have appeared up to this moment, and was used in the preparation of the extract.

As a result of 100 g of worms in 50 days received 700 g of the extract.

The method of treatment of diabetes personal preparation obtained by the method according to claim 1 illustrated in the drawings, in which figure 1 shows the projection area of diseased organs of the human body from the stomach, in figure 2 the projection area of diseased organs of the human body from the back, figure 3 scheme of the spine man. The proposed method of treatment consists in the following. The impact on the patient's body lead by personal application of the drug on the projection area of diseased organs on the body side of the abdomen and back, located closest to sick bodies and the projection point 1 (figure 1)that are responsible for immunity. Initially the drug is applied within 7-10 days daily in the amount of 0.5-1 ml of the lumbar spine (L1-L5) (see figure 3) and 0.5-1 ml per point 1, responsible for immunity, then, every day for 1.5-2 ml of projection points 1, 2 and 3 from the stomach (points 2, 3 - Pancreas) and 4, 5, 6 on the back (see figure 2) (v.4 - kidney, V.5 - stomach, V.6 - pancreas) evenly.

(See http://www.liveinternet.ru/users/3265720/post218750912/)

Example 1 (treatment of diabetes)

Man, 40 years old, type 1 diabetes type sugar rises up to 12-14%, the upper bound HELL is not stable (from 100 to 200 mm RT. Art.)

Personal drug was applied for 7 days daily in the amount of 0.5-1 ml of the lumbar spine (L1-L5) (see figure 3) and 0.5-1 ml per point 1 from the stomach that are responsible for immunity. Then, every day for 1.5-2 ml of projection points 1, 2 and 3 from the stomach and 4, 5, 6 on the back (see figure 2) evenly.

After 3 weeks of usage the pressure stabilized at normal (120×80), the blood sugar level is 6.8.

Che is ez 2 months: pressure is normal, sugar - 5,5.

At the moment the tool is applied periodically, sugar does not rise above 7.

At the moment the tool is applied periodically, the symptoms specified disease did not manifest.

1. The method of obtaining personal drug for the treatment of diabetes of earthworms in the diet which was used feed containing organic material, characterized in that the first Mature earthworms 20-30 days is placed in a medium consisting of organic matter, which additionally contains 5÷10% solution of urine of a sick person in the following ratio, wt.%:

Organics70÷85%
The solution urinerest

rate of not less than one kilogram of feed 30-40 g of worms, then adult worms were removed and within 3 months every 7-10 days to the remaining mass add fresh organic feed of the same composition, while maintaining the previous value of the mass of a new generation of worms and add the feed, after which adult worms are separated, placed in a container and sprayed with alcohol 60÷70% solution at the rate of 3-5 ml per 100 g of worms, mix thoroughly until the worms are no longer showing signs of life and then pour 60-70% alcohol solution and the calculation of 150-160 ml per 100 g worms and placed in a dark place for at least 10 days at a temperature of 17-24 degrees, moreover, the solution is daily subjected to stirring, and then the extract is separated from the precipitate.

2. Personal drug for the treatment of diabetes, obtained by the method of obtaining the drug from earthworms according to claim 1.

3. A method of treating diabetes personal preparation obtained by the method according to claim 1, characterized in that the impact on the patient's body lead by personal application of the drug on the projection area of diseased organs on the body side of the abdomen and back, located closest to sick bodies and the projection point responsible for immunity, and at first the drug is applied within 7-10 days daily in the amount of 0.5-1 ml of the lumbar spine in accordance with figure 3 and 0.5-1 ml per point 1 in accordance with figure 1, are responsible for immunity, then, daily 1.5-2 ml of projection points 1, 2 and 3 from the stomach in accordance with figure 1 and figure 4, 5, 6 on the back in accordance with figure 2 evenly.



 

Same patents:

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine, more specifically to a pharmaceutical composition possessing antithrombotic, thrombolytic, immunomodulatory, anti-inflammatory action, normalising lipid and carbohydrate metabolism, more specifically to the pharmaceutical composition of the substance Pijavitum (hereinafter referred to Pijavitum) made from lyophilised medicinal leech. The above pharmaceutical composition is presented in the form of an enteric coated tablet.

EFFECT: coating prevents the active ingredients of Pijavitum from destruction under action of the enzymes and acid medium of the stomach.

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to a new antineoplastic drug representing 2-isobutyl-4,6-dimethyl-5-oxypyrimidine of the general formula I specified below. The drug may be used for an adjuvant antineoplastic immune therapy. The invention also refers to a method for preparing 2-isobutyl-4,6-dimethyl-5-oxypyrimidine. According to the method, isocaproic acid amide reacts in ice-cold acetic acid with chloracetyl acetone to form the respective oxazole which reacts with aqueous ammonia which leads to preparation of the above compound.

EFFECT: what is disclosed is a manifested tumour growth inhibition with no signs of the toxic effect on somatic characteristics of tumour-carrier mice.

3 cl, 9 tbl, 6 ex

FIELD: medicine.

SUBSTANCE: what is presented is a method for simulating a delayed hyperresponsiveness to mycobacteria bovis. Avirulent mycobacteria bovis of the strain BCG are administered intracutaneously to albino guinea pigs produced by consanguineous mating of brother x sister (F2); that is followed by forming a group (groups) of animals showing various extents of an inflammatory response in reaction to the intracutaneous administration of mycobacteria bovis of the strain BCG 30-35 days later.

EFFECT: method is effective in studying the mechanisms of the delayed hyperresponsiveness and assessing the efficacy of antituberculosis agents.

2 tbl, 5 ex

FIELD: chemistry.

SUBSTANCE: agent, having adaptogenic and immunomodulating activity, containing medicinal marigold flower heads; rhaponticum carthamoides root and rhizome; horse-heal rhizome; nutmeg fruit; cardamom fruit; calamus root; sweet weed root; ginger rhizome; knotgrass; cinnamon bark; pomegranate; long red pepper; juniper fruit; leather bergenia black leaves; chitosan, taken in a defined amount.

EFFECT: agent has marked adaptogenic and immunomodulating activity.

10 tbl

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine, in particular to gastroenterology, and deal with treatment of ulcerative colitis and Crohn's disease. Method of treatment includes introduction into organism of therapeutically efficient quantity of attaching cells from placenta, cultivated in such a way as not to differentiate into adipocytes or osteocytes. Also claimed is application of said cells for obtaining medication, intended for treatment of ulcerative colitis or Crohn's disease. Claimed produced product for treatment of ulcerative colitis or Crohn's disease includes in packing form pharmaceutically efficient quantity of said cells.

EFFECT: inventions ensure essential reduction of inflammatory process in colon in modelling of said diseases, as well as due to pathological mechanisms of treatment in addition to T-lymphocyte suppression.

31 cl, 5 ex, 12 tbl, 16 dwg

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly to paediatrics and neonatology, and can be used for treating small premature infants at the hospital stage of developmental care. A therapeutic complex comprises administering a probiotic preparation into the newborns. The preparation is presented with a liquid probiotic containing E.faecium L3 109 CFU in 1 ml. If the enteral nutrition volume of the newborn is 5 ml or more, this preparation is orally administered in a dose of 0.5 ml 3 times a day for 14 days.

EFFECT: method is effective in children with a very low body weight, promotes normalising the intestinal microflora and reducing a rate of manifestations of infectious complications.

2 ex, 3 dwg, 3 tbl

FIELD: chemistry.

SUBSTANCE: group of inventions relates to biotechnology and medicine. Disclosed is a polysaccharide which is isolated from the Bifidobacterium infantis NCIMB 41003 strain and has the structure [-β(1,3)-D-GalpNAc-β(1,4)-D-Glcp-]n, where said disaccharide unit repeats n times, which yields a polysaccharide with molecular weight greater than 100000 Da. The polysaccharide exhibits immunomodulating activity and is used in preparing medicinal agents for treating or preventing undesirable inflammatory activity, undesirable gastrointestinal inflammatory activity, rheumatoid arthritis and autoimmune disorders.

EFFECT: pharmaceutical composition for treating and preventing inflammatory disorders and a food product containing the isolated polysaccharide are disclosed.

9 cl, 6 dwg, 3 ex

FIELD: chemistry.

SUBSTANCE: invention relates to a compound CL168 of general structural formula I where R is oxygen. The invention also relates to a method of producing a compound of formula I and use of the compound of formula I to produce a medicinal agent for preventing or treating tumorous and immunological diseases.

EFFECT: compound of formula I for producing a medicinal agent for preventing or treating tumorous and immunological diseases.

4 cl, 11 tbl, 19 ex

Iimmunomodulator // 2504371

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, namely to an immunomodulator. An immunomodulator for the immunocorrection accompanying the integrated treatment of chronic non-specific pulmonary diseases, chronic obstructive pulmonary disease, bronchial obstruction syndrome, chronic bronchial pneumonia, pulmonary fibrosis, tracheobronchitis, chronic laryngitis, pulmonary, tracheal and pharyngeal cancer; the immunomodulator is prepared by mixing a water infusion of rose bay leaves and a water infusion of yellow melilot taken in equal proportions, with a cattle lung and larynx powder, settling the prepared mixture, keeping on a boiling water bath, cooling; further, the mixture is filtered; the prepared solution is added with cattle blood serum containing leukaemia oncovirus antibodies, hemlock infusion, ascorbic and sorbic acids until all the ingredients fully dissolved; the prepared solution is placed in the water bath, cooled, filtered, sterilised under certain conditions.

EFFECT: above preparation provides higher effectiveness and reduces the length of treating the above diseases, and ensures the higher immunobiological properties of the human body.

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, namely to an extract of one or more bacterial strains Lactobacillus. The extract of one or more bacterial strains Lactobacillus representing a soluble extract, wherein the extract contains chemically modified bacterial molecules prepared by the action of an alkaline medium on one or more bacterial strains Lactobacillus; the extract is effective in treating diseases associated with the anti-inflammatory cytokine production imbalance. A method for preparing the extract of one or more bacterial strains Lactobacillus. A pharmaceutical composition effective for reducing at least one symptom associated with at least one condition specified in a respiratory disorder, an allergic condition, an urinary disorder and a gastric disorder, containing the extract. A nutritional composition. A pharmacological composition effective in treating the diseases associated with the anti-inflammatory cytokine production imbalance, containing the extract. A method of relieving the above symptoms. The extract prepared by the above method.

EFFECT: extract is effective in treating the diseases associated with the anti-inflammatory cytokine production imbalance.

21 cl, 7 dwg, 23 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: complex of biologically active substances for treating and preventing cardiovascular diseases, recovered from sea urchin gonads Strongylocentrotus droebachiensis free from ballast substances, prepared by extraction of the purified gonads in 95% ethanol under certain conditions, separation of a dry ethanolic extract and drying. An agent for treating and preventing cardiovascular diseases containing the complex of biologically active substances.

EFFECT: complex and agent are effective in treating and preventing cardiovascular diseases.

4 cl, 1 dwg, 4 tbl, 11 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: present invention refers to a formulation of a traditional Chinese medicine for treating bronchial asthma, and a method for preparing it. The traditional Chinese medical composition is prepared of pure herbal raw materials, including ephedra herb (Herba Ephedrae), ginkgo seeds (Semen Ginkgo), mulberry bark (Cortex Mori), skullcap root (Radix Scutellariae), bitter apricot seeds (Semen Armeniacae Amarum), pinellia rhinzomes (Rhizoma Pinelliae), perilla fruit (Fructus Perillae), foalfoot blossom (Flos Farfarae), red peony root (Radix Paeoniae Rubra), houttuynia herb (Herba Houttuyniae), trichosanthis root (Radix Trichosanthis), forsythia fruit (Fructus Forsythiae).

EFFECT: traditional Chinese medical composition is effective in treating bronchial asthma.

11 cl, 7 tbl, 12 ex

FIELD: chemistry, pharmacology.

SUBSTANCE: medication for prevention and treatment of andrological diseases represents dried alcohol extract of gonads of sea urchin Strongylocentrotus droebachiensis, obtained by successive processing of gonads with two-phase extractant chloroform-ethanol, then with 95% ethyl alcohol, keeping with periodical mixing, solid residue after separation of liquid extract is poured with 70% ethyl alcohol and kept with mixing, separated and dried under specified conditions.

EFFECT: medication is efficient for prevention and treatment of andrological diseases.

3 cl, 4 tbl, 6 ex

FIELD: chemistry.

SUBSTANCE: invention relates to biotechnology and can be used to produce biologically active collagen peptides from marine hydrobionts. Patiria pectinifera starfish is dehydrated with 96% ethyl alcohol and then demineralised with 1-2 N solution of an inorganic acid with ratio of the raw material to inorganic acid of 1:(3-5) for 1-3 days. The demineralised raw material is washed from traces of acid and water-soluble impurities with distilled water, after which the material is hydrolysed with an alkali solution with ratio of raw material to the alkali solution of 1:(3-5) in order to remove non-collagen proteins and washed with distilled water at temperature of 2-4°C. The obtained starfish collagen shells are homogenised. The homogenate is diluted with distilled water; pH of the suspension is brought to a value equal to 8.0-8.5 with an alkali solution and hydrolysed with 1% collagenase solution with ratio of homogenate to enzyme of (100-200):1 and temperature of 30-40°C for 3-5 hours, pH 8.5-7.0. The enzyme is inactivated at 80-90°C for 10-15 minutes. The hydrolysate solution is filtered to remove non-hydrolysed collagen, subjected to ultra-filtration through a 30 kD membrane filter to remove the inactivated enzyme; the end product, having antitumour, anticoagulant, wound-healing, anti-inflammatory, antioxidant activity, capacity to inhibit collagenase and angiotensin converting enzyme and which is a complex of collagen peptides with a high-molecular weight component weighing 22-23 kD, is concentrated in a vacuum and lyophilised.

EFFECT: obtaining a product, having antitumour, anticoagulant, wound-healing, anti-inflammatory and antioxidant activity.

2 cl, 7 tbl, 2 ex

FIELD: chemistry.

SUBSTANCE: invention relates to field of biotechnology, in particular to bactericidal preparations with lysozyme activity. Water solutions of silver nitrate and lysozyme are mixed in specified ratio with obtaining reduced metal silver. Reduced metal silver is stabilized by addition of water gelatin solution in specified ratio. Obtained mixture is subjected to UV-irradiation with continuous mixing for 25-30 minutes, in the range of short-wave radiation 254 nm, for 25-30 minutes in the range of long-wave radiation 365 nm, for 55-60 minutes in the range of short-wave radiation 254 nm. Dialysis of processed mixture is carried out for 24-30 hours with continuous mixing with application of bidistilled water with further drying under vacuum.

EFFECT: invention makes it possible to obtain preparation which is non-toxic and stable in sodium chloride solution.

2 tbl, 3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmacy, medicine and veterinary science, particularly new drugs for inflammatory and allergic diseases. The assigned problem preparing a non-toxic, easy-to-use and storage-stable drug in the form of eye drops, intranasal drops and spray and causing anti-inflammatory and antiallergic action is solved by creating a composition containing a pigment-mineral complex of sea-urchin shell (0.05-2.0%) containing spinochromes B, D, dimer polyhydroxynaphthoquinone and a mineral ingredient (calcium, magnesium, phosphor, sodium, potassium) in the form of water-soluble salts, a co-solvent (0.01-10%), a preserving agent (0.01-0.2%), an antioxidant (0.01-0.2%), an acidity regulator (to pH 6.0-8.0) and water (to 100%).

EFFECT: what is described is the experimentally specified method for preparing the agent according to the invention eliminating the oxidation of the pigment-mineral complex as early as the stage of preparing.

3 cl, 3 tbl, 1 dwg, 6 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, namely an agent possessing anti-inflammatory action. The agent possessing anti-inflammatory action contains as active ingredient in the form of a complex prepared of a coelomic fluid of sea urchins containing peptides and amino acids at a certain ratio of the ingredients.

EFFECT: agent possesses a manifested anti-inflammatory effect.

2 cl, 2 tbl, 10 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, namely to a method for preparing a pharmaceutical preparation for treating inflammatory intestinal diseases. The method for preparing a pharmaceutical preparation for oral administration for inflammatory intestinal diseases, particularly chronic inflammatory gastrointestinal diseases containing a storage-stable suspension of vital eggs of the parasitic, non-pathogenic to humans helminthes Trichuris suis, which involves preparing the suspension of helminth eggs in an acid at pH max. 2 at the first stage; at the following stage, the pH value is increased to min. 4, and a pharmacologically acceptable preserving agent is added. A pharmaceutical preparation for oral administration for inflammatory intestinal diseases, particularly chronic inflammatory intestinal diseases. The use of the pharmaceutical preparation for oral administration for inflammatory alimentary diseases, particularly chronic inflammatory alimentary diseases.

EFFECT: method enables more effective storage of the produced preparation of vital helminth eggs not accompanied by dangerous intergrowths of fungal spores and yeast propagation.

11 cl, 3 tbl, 5 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine, biotechnology, as well as to pharmaceutical, food and cosmetic industries, and concerns an agent made of sea urchin viscera being waste after edible gonads have been separated. The agent with anti-inflammatory and immunotropic activity is characterised by the fact that it represents an alcoholic extract prepared of sea urchin viscera after gonad separation, containing 10-15% of peptides, 35-45% of amino acids, 4-8% of phospholipids, trace substances, and has the following characteristics: molecular weight of the peptide fractions as determined by polyacrylamide gel electrophoresis is 19-15 kDa, 6-3,5 kDa and less than 3.5 kDa. The agent is prepared by separating gonads from sea urchins, taking the viscera, extraction in ethanol in ratio 1:1-3 at temperature 0 to plus 10°C for 2 h to 10 days, separation of a liquid portion to produce a water-alcohol extract, alcohol distillation, and drying.

EFFECT: invention provides preparing the safe agent with the evident therapeutic effect.

3 cl, 7 ex, 1 tbl

FIELD: medicine.

SUBSTANCE: invention refers to pharmaceutical and food industry, namely a method for producing alkyl-glycerol esters of sea fats. The method for producing alkyl-glycerol esters of sea fats involving hydrolysis of sea fat, acidation of a fatty mixture, water washing, first crystallisation of the mixture of acetone and hexane, filtration, second crystallisation of the residue of acetone or hexane, filtration and drying of an end product under certain conditions.

EFFECT: method enables reducing a time of technological process.

2 cl, 21 ex

FIELD: medicine, pharmaceutical, cosmetic and food industry.

SUBSTANCE: invention relates to methods for producing biologically active preparation - adaptogen from marine animal raw. Method involves destruction and hydrolysis of marine animal raw among the following group: sea urchins, trepangs, mussels, squids and white whale followed by separation of cytoplasmic fraction and addition of food acid polyvalent metal salt solution followed by correction of acidity, drying and transforms to form useful for storage. Invention expands functional abilities of the preparing preparation for providing adaptation to unfavorable conditions of environment and stimulation processes in healing wounds and burns and regeneration of post-traumatic injuries.

EFFECT: improved method for producing, valuable properties of adaptogen.

12 cl

Up!